Minerva Surgical to Present at Upcoming Investor Conferences
SANTA CLARA, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the following investor conferences:
- H.C. Wainwright Global Investment Conference
The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7:00 a.m. Eastern Time on Tuesday, May 24, 2022.
- UBS Global Healthcare Conference 2022
Presenting on Wednesday, May 25, 2022 at 7:45 a.m. Eastern Time at the Lotte New York Palace Hotel in New York
The audio webcasts and replays of the presentations may be accessed through the “Recent Events” section of Minerva’s website at http://ir.minervasurgical.com.
About Minerva Surgical, Inc.
Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The Company has established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. The Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.
INVESTOR RELATIONS CONTACT